Citation Impact
Citing Papers
Depression Screening and Patient Outcomes in Cardiovascular Care
2008
Depression and Anxiety as Predictors of 2-Year Cardiac Events in Patients With Stable Coronary Artery Disease
2008
Recent Evidence Linking Coronary Heart Disease and Depression
2006
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
Electrical isolation of a substrate after myocardial infarction: a novel ablation strategy for unmappable ventricular tachycardias--feasibility and clinical outcome
2014
The Significance of Depression in Older Patients After Myocardial Infarction
2002
Comparison of β-Blockers, Amiodarone Plus β-Blockers, or Sotalol for Prevention of Shocks From Implantable Cardioverter Defibrillators<SUBTITLE>The OPTIC Study: A Randomized Trial</SUBTITLE>
2006
Long-Term Trends in the Incidence of and Survival with Heart Failure
2002 Standout
Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes
2006
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
1998 Standout
Psychopathology in Patients with ICDs over Time: Results of a Prospective Study
2009
Marriage and health: His and hers.
2001 Standout
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction
2004 Standout
Relationship of Depression to Death or Hospitalization in Patients With Heart Failure
2007
Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies
2006 Standout
Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research
2011
Do depression and anxiety predict recurrent coronary events 12 months after myocardial infarction?
2000
Mortality and Quality of Life 12 Months After Myocardial Infarction: Effects of Depression and Anxiety
2001
Depression as a predictor for coronary heart disease
2002
Production and Characterization of γ-Polyglutamic Acid Nanoparticles for Controlled Anticancer Drug Release
2008
Paclitaxel poliglumex for ovarian cancer
2011
Sleep Quality and Sleepiness in Persons with Implantable Cardioverter Defibrillators: Outcome from a Clinical Randomized Longitudinal Trial
2012
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
The association of depression and anxiety with medical symptom burden in patients with chronic medical illness
2007
Depression as a Risk Factor for Mortality in Patients With Coronary Heart Disease: A Meta-analysis
2004
Depression, mortality, and medical morbidity in patients with coronary heart disease
2003
Why is depression bad for the failing heart? a review of the mechanistic relationship between depression and heart failure
2004
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
2009 Standout
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Depression and Anxiety in Heart Failure
2005
Antipsychotic-Related QTc Prolongation, Torsade de Pointes and Sudden Death
2002
Social Relationships and Mortality Risk: A Meta-analytic Review
2010 Standout
Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy
2008 Standout
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Antibody neutralization and escape by HIV-1
2003 StandoutNature
Polymer conjugates as anticancer nanomedicines
2006 Standout
Psychological Distress as a Predictor of CHD Events in Men: The Effect of Persistence and Components of Risk
2005
Protein folding and misfolding
2003 StandoutNature
Sertraline Treatment of Major Depression in Patients With Acute MI or Unstable Angina
2002
Depression in Heart Failure
2006 Standout
Psychophysiological and Cortisol Responses to Psychological Stress in Depressed and Nondepressed Older Men and Women With Elevated Cardiovascular Disease Risk
2006
Even minimal symptoms of depression increase mortality risk after acute myocardial infarction
2001
EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA)
2009
Prevalence of depression in survivors of acute myocardial infarction
2005
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
Psychological Theories of Depression: Potential Application for the Prevention of Acute Coronary Syndrome Recurrence
2004
Depression and Medication Adherence in Outpatients With Coronary Heart Disease
2005
Mild Traumatic Brain Injury in U.S. Soldiers Returning from Iraq
2008 Standout
Subjective wellbeing, health, and ageing
2014 StandoutNobel
Major Depressive Disorder
2008 Standout
Probing the free-energy surface for protein folding with single-molecule fluorescence spectroscopy
2002 Nature
Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction
2001
Reflections on Depression as a Cardiac Risk Factor
2005
Health-Related Quality of Life Consequences of Implantable Cardioverter Defibrillators
2007
In-hospital symptoms of depression do not predict mortality 3 years after myocardial infarction
2002
Congestive Heart Failure in the Community
1999
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Patient Nonadherence To Medication in Inflammatory Bowel Disease
2003
Cost-Effectiveness of Implantable Cardioverter–Defibrillators
2005
Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial
2010
Amphiphilic poly(l-amino acids) — New materials for drug delivery
2012
Depression and Other Psychological Risks Following Myocardial Infarction
2003
Interventions to Enhance Patient Adherence to Medication Prescriptions
2002 Standout
Plant-derived compounds in clinical trials
2007
Depression in patients with cardiac disease
2000
Depression and Late Mortality After Myocardial Infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) Study
2004
Prognostic Association of Depression Following Myocardial Infarction With Mortality and Cardiovascular Events: A Meta-analysis
2004
Psychological Predictors of Adherence and Outcomes Among Patients in Cardiac Rehabilitation
2002
Depressive symptoms and the risk of sudden cardiac death among the elderly
2003
Effects of depression and anxiety on mortality and quality-of-life 4 months after myocardial infarction
2000
Illness Perceptions After Myocardial Infarction
2010
Impact of Depression and Antidepressant Treatment on Heart Rate Variability: A Review and Meta-Analysis
2010 Standout
Depression as a Risk Factor for Coronary Artery Disease: Evidence, Mechanisms, and Treatment
2004
Postmyocardial Infarction Mortality in Relation to Depression: A Systematic Critical Review
2005
Use of implantable cardioverter-defibrillators for primary prevention in older patients: A systematic literature review and meta-analysis
2011
Management of patients receiving implantable cardiac defibrillator shocks: Recommendations for acute and long-term patient management
2010
Adherence to Medication
2005 Standout
Prevalence and predictors of anxiety and depression in a sample of chronic heart failure patients with left ventricular systolic dysfunction
2005
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Chemical treatment of γ-Al2O3 and its influence on the properties of Co-based catalysts for Fischer–Tropsch synthesis
2003
Preclinical Efficacy of the Camptothecin-Polymer Conjugate IT-101 in Multiple Cancer Models
2006
The surface modification effects of silica support by organic solvents for Fischer–Tropsch synthesis catalysts
2006
Educational and Psychological Interventions to Improve Outcomes for Recipients of Implantable Cardioverter Defibrillators and Their Families
2012
IR studies on the preservation of RhCo3 clusters on the surface of SiO2
1996
Drug Discovery and Natural Products: End of an Era or an Endless Frontier?
2009 StandoutScience
Therapeutic Nanoparticles for Drug Delivery in Cancer
2008 Standout
EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias
2009
Cobalt-containing catalysts supported by synthetic Zn- and Mg-stevensites and their performance in the Fischer–Tropsch synthesis
2001
How to Respond to an Implantable Cardioverter-Defibrillator Shock
2005
Transcatheter Mitral-Valve Repair in Patients with Heart Failure
2018 Standout
High temperature reduction with hydrogen, phase composition, and activity of cobalt/silica catalysts
2003
Effect of zirconia-modified alumina on the properties of Co/γ-Al2O3 catalysts
2003
Strong dependence on pressure of the performance of a Co/SiO2 catalyst in Fischer–Tropsch slurry reactor synthesis
2005
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
Formation of bimetallic RhCo3 clusters from monometallic carbonyl clusters on SiO2 as probed by hydroformylation
1997
The formation of cobalt silicates on Co/SiO2 under hydrothermal conditions
1995
Formation of Diphosphates. A NMR Study on the Mechanism and Stereochemistry of Diphosphate Formation from Chiral Dioxaphosphorinanes
2000 StandoutNobel
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Advances in the Development of Novel Cobalt Fischer−Tropsch Catalysts for Synthesis of Long-Chain Hydrocarbons and Clean Fuels
2007 Standout
Management of Ventricular Tachycardia in the Setting of a Dedicated Unit for the Treatment of Complex Ventricular Arrhythmias
2013
Depression as a Risk Factor for Coronary Artery Disease: Evidence, Mechanisms, and Treatment
2004
Depression and Coronary Heart Disease
2008 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
Polymeric Nanostructures for Imaging and Therapy
2015
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Appropriate and Inappropriate Ventricular Therapies, Quality of Life, and Mortality Among Primary and Secondary Prevention Implantable Cardioverter Defibrillator Patients
2005
Nanoparticles in Photodynamic Therapy
2015 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Implantable Cardioverter Defibrillators in Primary and Secondary Prevention
2003
Effect of support and calcination on the properties of cobalt catalysts prepared by gas phase deposition
2000
Quality of Life and Psychological Status of Patients With Implantable Cardioverter Defibrillators
2006
On Cobalt Silicate Formation during High-Temperature Calcination of Impregnated Cobalt/Silica Catalysts
1998
Cobalt Cluster Effects in Zirconium Promoted Co/SiO2 Fischer–Tropsch Catalysts
1999
Preparation and characterization of Fischer–Tropsch active Co/SiO2 catalysts
1999
A Phase I and Pharmacokinetic Study of Paclitaxel Poliglumex (XYOTAX), Investigating Both 3-Weekly and 2-Weekly Schedules
2005
Depression, Heart Rate Variability, and Acute Myocardial Infarction
2001
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Multistage nanoparticle delivery system for deep penetration into tumor tissue
2011 StandoutNobel
Fischer−Tropsch Synthesis with Cobalt Catalysts Supported on Mesoporous Silica for Efficient Production of Diesel Fuel Fraction
2003
Chemistry and Properties of Nanocrystals of Different Shapes
2005 Standout
Characterisation of Co/SiO2 catalysts prepared from Co(acac)3 by gas phase deposition
2001
New directions in single-molecule imaging and analysis
2007 StandoutNobel
An Open-Label Study of Nefazodone Treatment of Major Depression in Patients with Congestive Heart Failure
2003
Nanometer resolution imaging and tracking of fluorescent molecules with minimal photon fluxes
2016 StandoutScienceNobel
Measuring agreement in method comparison studies
1999 Standout
Metal–Organic Frameworks in Biomedicine
2011 Standout
pH-Operated Nanopistons on the Surfaces of Mesoporous Silica Nanoparticles
2010 StandoutNobel
Metal–support interaction in Co/SiO2 and Co/TiO2
2000
Medication Adherence
2009 Standout
Fischer–Tropsch synthesis over silica supported cobalt catalysts: mesoporous structure versus cobalt surface density
2003
Bimetallic catalysis: CO hydrogenation over palladium–cobalt catalysts prepared by sol/gel method
1999
Towards a rational design of resolving agents. Part III. structural study of two pairs of diastereomeric salts of ephedrine and a cyclic phosphoric acid
1991
Novel utilization of mesoporous molecular sieves as supports of cobalt catalysts in Fischer–Tropsch synthesis
2004
Solar Energy Supply and Storage for the Legacy and Nonlegacy Worlds
2010 Standout
Works of Brian Baker being referenced
Design and Rationale for a Randomized, Controlled Trial of Interpersonal Psychotherapy and Citalopram for Depression in Coronary Artery Disease (CREATE)
2006
Effects of Citalopram and Interpersonal Psychotherapy on Depression in Patients With Coronary Artery Disease
2007
An automated enzymic micromethod for the measurement of fat in human milk
1987
Marital cohesion and ambulatory blood pressure in early hypertension
1999
Electrocardiographic Effects of Fluoxetine and Doxepin in Patients With Major Depressive Disorder
1997
Determinants of left ventricular mass in early hypertension☆
1998
Paclitaxel poliglumex (XYOTAX; CT-2103): an intracellularly targeted taxane
2005
The influence of age, gender, and race on the prevalence of depression in heart failure patients
2004
An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial)
1999
Poor Adherence to Placebo or Amiodarone Therapy Predicts Mortality
1999
Depression and Risk of Sudden Cardiac Death After Acute Myocardial Infarction: Testing for the Confounding Effects of Fatigue
1999
Distance Estimates from Paramagnetic Enhancements of Nuclear Relaxation in Linear and Flexible Model Peptides
1999
Outcomes of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Receiving an Oral Anticoagulant and Dual Antiplatelet Therapy
2015
Quality of life in the Canadian Implantable Defibrillator Study (CIDS)
2002
Poly-(L)-Glutamic Acid-Paclitaxel (CT-2103) [XYOTAX™], a Biodegradable Polymeric Drug Conjugate
2004
Inability of the Activated Partial Thromboplastin Time to Predict Heparin Levels
1997
Synthesis and in Vivo Antitumor Activity of Poly(l -glutamic acid) Conjugates of 20(S)-Camptothecin
2002
Characterization of cobalt Fischer-Tropsch catalysts I. Unpromoted cobalt-silica gel catalysts
1995
Quality of life in the Canadian Implantable Defibrillator Study (CIDS)
2002
Autonomie Correlates of Antidepressant Treatment Using Heart-Rate Variability Analysis
1998
Dynamic molecular surface areas
1989
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure. Results of a Veterans Administration Cooperative Study
1987